Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
$406M |
| 2 |
Baidu
BIDU
|
$382M |
| 3 |
AGN
Allergan plc
AGN
|
$366M |
| 4 |
Bristol-Myers Squibb
BMY
|
$322M |
| 5 |
NextEra Energy, Inc.
NEE
|
$312M |
Top Sells
| 1 |
Tesla
TSLA
|
$1.66B |
| 2 |
Meta Platforms (Facebook)
META
|
$370M |
| 3 |
Pfizer
PFE
|
$343M |
| 4 |
Gilead Sciences
GILD
|
$331M |
| 5 |
Amazon
AMZN
|
$282M |
Sector Composition
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.73% |
| 3 | Consumer Staples | 9.8% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Costco
COST
$418B
| $364M | 0.35% | 1,275,218 +989,205 | +346% | +$282M |
|
52
Dropbox
DBX
$7.84B
| $347M | 0.34% | 19,196,526 +1,597,010 | +9% | +$28.9M |
|
53
Exelixis
EXEL
$10.1B
| $346M | 0.34% | 20,071,060 +2,117,134 | +12% | +$36.5M |
|
54
Jazz Pharmaceuticals
JAZZ
$7.75B
| $343M | 0.33% | 3,438,550 -110,821 | -3% | -$11.1M |
|
55
United Therapeutics
UTHR
$13.8B
| $340M | 0.33% | 3,590,223 +45,790 | +1% | +$4.34M |
|
56
Icon
ICLR
$13.8B
| $340M | 0.33% | 2,501,319 +154,260 | +7% | +$21M |
|
57
BP
BP
$90.8B
| $339M | 0.33% | 13,904,393 -3,185,869 | -19% | -$77.7M |
|
|
ALXN
58
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $338M | 0.33% | 3,763,502 +32,358 | +0.9% | +$2.91M |
|
59
GE Aerospace
GE
$292B
| $338M | 0.33% | 42,532,197 -33,092,729 | -44% | -$263M |
|
60
Incyte
INCY
$16.5B
| $337M | 0.33% | 4,602,260 +1,001,257 | +28% | +$73.3M |
|
|
MBT
61
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $332M | 0.32% | 43,668,397 +4,055,428 | +10% | +$30.8M |
|
62
Progressive
PGR
$145B
| $322M | 0.31% | 4,361,868 -998,018 | -19% | -$73.7M |
|
63
Teradyne
TER
$18.8B
| $316M | 0.31% | 5,841,350 +439,601 | +8% | +$23.8M |
|
|
HZNP
64
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $315M | 0.31% | 10,623,675 +523,000 | +5% | +$15.5M |
|
|
65
NextEra Energy, Inc.
NEE
$148B
| $312M | 0.3% | +1,295,026 | New | +$312M |
|
66
CME Group
CME
$96B
| $311M | 0.3% | 1,796,229 -338,189 | -16% | -$58.5M |
|
67
American Tower
AMT
$95.5B
| $304M | 0.3% | 1,398,209 +402,355 | +40% | +$87.6M |
|
68
NetEase
NTES
$86.2B
| $302M | 0.29% | 941,900 -182,817 | -16% | -$58.7M |
|
69
Verizon
VZ
$186B
| $299M | 0.29% | 5,558,127 +4,303,734 | +343% | +$231M |
|
70
AT&T
T
$209B
| $299M | 0.29% | +10,244,486 | New | +$299M |
|
|
ABMD
71
DELISTED
Abiomed Inc
ABMD
| $297M | 0.29% | 2,048,000 -275,023 | -12% | -$39.9M |
|
72
Public Storage
PSA
$51.7B
| $292M | 0.28% | 1,472,338 -59,534 | -4% | -$11.8M |
|
73
Cogent Communications
CCOI
$1.88B
| $292M | 0.28% | 3,567,366 -21,000 | -0.6% | -$1.72M |
|
74
F5
FFIV
$18B
| $290M | 0.28% | 2,719,074 -146,300 | -5% | -$15.6M |
|
|
MOMO
75
Hello Group
MOMO
$1.33B
| $289M | 0.28% | 13,340,297 -12,106 | -0.1% | -$263K |
|